Literature DB >> 34355645

COVID-19: clinical presentation and detection methods.

Madhulika Pradhan1, Kamal Shah2, Amit Alexander3, Sunita Minz4, Manju Rawat Singh5, Deependra Singh5, Krishna Yadav5, Nagendra Singh Chauhan6.   

Abstract

The unending outburst of COVID-19 has reinforced the necessity of SARS-CoV-2 identification approaches for the prevention of infection transmission and the proper care of severe and critical patients. As there is no cure, a prompt and reliable diagnosis of SARS-CoV2 is vital to counter the spread and to provide adequate care and treatment for the infection. Currently, RT-PCR is a gold standard detection method for the qualitative and quantitative detection of viral nucleic acids. Besides, enzyme-linked immunosorbent assay is also a primarily used method for qualitative estimation of viral load. However, almost all the detection methods have their pros and cons in terms of specificity, accuracy, sensitivity, cost, time consumption, the need for sophisticated laboratories, and the requirement of skilled technical experts to carry out the detection tests. Thus, it is suggested to integrate different techniques to enhance the detection efficiency and accurateness for SARS-CoV2. This review focuses on preliminary, pre-confirmatory, and confirmatory methods of detection such as imaging techniques (chest-X-ray and chest- computed tomography), nucleic acid detection methods, serological assay methods, and viral culture and identification methods that are currently being employed to detect the presence of SARS-CoV-2 infection along with recent detection method and applicability for COVID-19.

Entities:  

Keywords:  COVID-19; ELISA; corona; serological assay; viral culture

Mesh:

Substances:

Year:  2021        PMID: 34355645     DOI: 10.1080/15321819.2021.1951291

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  5 in total

1.  Seroprevalence Survey of Anti-SARS-CoV-2 Antibodies in a Population of Emilia-Romagna Region, Northern Italy.

Authors:  Stefania Paduano; Pasquale Galante; Nausicaa Berselli; Luca Ugolotti; Alberto Modenese; Alessandro Poggi; Marcella Malavolti; Sara Turchi; Isabella Marchesi; Roberto Vivoli; Paola Perlini; Rossana Bellucci; Fabriziomaria Gobba; Marco Vinceti; Tommaso Filippini; Annalisa Bargellini
Journal:  Int J Environ Res Public Health       Date:  2022-06-27       Impact factor: 4.614

Review 2.  Present scenarios and future prospects of herbal nanomedicine for antifungal therapy.

Authors:  Rahul Yadav; Madhulika Pradhan; Krishna Yadav; Anand Mahalvar; Homesh Yadav
Journal:  J Drug Deliv Sci Technol       Date:  2022-05-13       Impact factor: 5.062

3.  Peritoneal effusion as unusual complication post COVID 19 infection.

Authors:  Ameen Alhamad; Haidara Bohsas; Eman Mohammed Sharif Ahmed; Agyad Bakkour; Fateh Kashkash; Abdullah Khouri
Journal:  Ann Med Surg (Lond)       Date:  2022-05-31

4.  Evaluation of factors contributing to variability of qualitative and quantitative proficiency testing for SARS-CoV-2 nucleic acid detection.

Authors:  Yongzhuo Zhang; Xia Wang; Chunyan Niu; Di Wang; Qingfei Shen; Yunhua Gao; Haiwei Zhou; Yunjing Zhang; Yan Zhang; Lianhua Dong
Journal:  Biosaf Health       Date:  2022-09-07

Review 5.  Theranostic efficiency of biosurfactants against COVID-19 and similar viruses - A review.

Authors:  Manoj Kumar Sarangi; Sasmita Padhi; L D Patel; Goutam Rath; Sitansu Sekhar Nanda; Dong Kee Yi
Journal:  J Drug Deliv Sci Technol       Date:  2022-09-06       Impact factor: 5.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.